Abstract:Cancer stands out as a major global public health concern and a significant impediment to increasing life expectancy worldwide. Natural bioactives derived from plants are renowned for their efficacy in treating various types of cancer. Andrographis paniculata (Burm.f.) is a well-known plant traditionally employed in diverse medical systems across the globe. The 2-AEH2P monophosphoester, a molecule intricately involved in phospholipid turnover, demonstrates antiproliferative effects across a broad spectrum of cancer types. This study aims to assess the antitumor, antiproliferative, and pharmacological effects of andrographolide at different concentrations, both individually and in conjunction with 2-aminoethyl dihydrogen phosphate. The cytotoxicity of the treatments was evaluated using the colorimetric MTT method, cell cycle phases, mitochondrial electrical potential, and markers expression via flow cytometry, while the pharmacological effects were assessed using SynergyFinder software 3.0. Treatments with A. paniculata, isolated at concentrations of 10%, 30%, and 50% of andrographolide, induced cell death in tumor cells, resulting in a reduction in mitochondrial electrical potential and alterations in cell cycle phases, particularly a decrease in the population of MDA MB-231 cells in the G0/G1 phase. The combination treatments exhibited significant cytotoxicity toward tumor cells, with minimal toxicity observed in normal fibroblast cells FN1. This led to a reduction in mitochondrial electrical potential and cell cycle arrest in the S phase for MDA MB-231 cells. Across all concentrations, the combined treatments demonstrated a synergistic pharmacological effect, underscoring the efficacy of the association. There was a change in the markers involved in cell death, such as p53, caspase 3, Bcl-2, and cytochrome c, suggesting the induction of regulated cell death. Markers associated with progression and proliferation, such as cyclin D1 and p21, corroborate the findings for cytotoxicity and cell cycle arrest.

Synergistic anticancer effects of andrographolide and paclitaxel against A549 NSCLC cells.

Synergistic Effects of Tanshinone IIA and Andrographolide on the Apoptosis of Cancer Cells Via Crosstalk Between P53 and Reactive Oxygen Species Pathways.

Andrographolide Enhances 5-Fluorouracil-induced Apoptosis Via Caspase-8-dependent Mitochondrial Pathway Involving P53 Participation in Hepatocellular Carcinoma (SMMC-7721) Cells.

Synergistic Anti-Cancer Effects of Arsenic Trioxide and Paclitaxel on Human Malignant Lymphocytes.

Synergistic Effects of TOR Combined with EADM on Growth and Apoptosis in Human Lung Cancer Cell Lines A549 and H1299

Enhanced Antitumor Efficacy Achieved Through Combination of nsPEFs and Low-Dosage Paclitaxel.

[Synergistic Effects of Paclitaxel and Gemcitabine on Androgen-Independent Prostate Cancer].

[The Synergistic Effects of Paclitaxel and Gemcitabine on Prostate Cancer Cell Line PC-3].

[Effect of Ginseng Rare Ginsenoside Components Combined with Paclitaxel on A549 Lung Cancer].

Synergistic Mitosis-Arresting Effects of Arsenic Trioxide and Paclitaxel on Human Malignant Lymphocytes

Synergistic Effects of Apigenin and Paclitaxel on Apoptosis of Cancer Cells.

Synergistic Effects of Paclitaxel and Retinoic Acid on Prostate Cancer Cell Line PC-3

Synergistic Anticancer Activity of Combined Use of Caffeic Acid with Paclitaxel Enhances Apoptosis of Non-Small-Cell Lung Cancer H1299 Cells in Vivo and in Vitro

Molecular Mechanism of Synergistic Antitumor Activity and Induced Apoptosis of Zoledronic Acid and Paclitaxel

Cytotoxic Effect of Andrographis paniculata Associated with 2-Aminoethyl Dihydrogen Phosphate in Triple-Negative Breast Cells

Synergistic Anti-Tumor Effects of Axitinib and Doxorubicin

Synergistic Anticancer Effect of a Combination of Paclitaxel and 5-Demethylnobiletin Against Lung Cancer Cell Line In Vitro and In Vivo

Combined Treatment with Apatinib and Docetaxel in A549 Xenograft Mice and Its Cellular Pharmacokinetic Basis

Synergistic Antitumor Effects of Berbamine and Paclitaxel Through ROS/Akt Pathway in Glioma Cells.

Andrographolide Enhances Cisplatin-Mediated Anticancer Effects in Lung Cancer Cells Through Blockade of Autophagy.

Effects of SAHA combined with PTX on survival and apoptosis of human paclitaxel-resistant ovarian cancer cells